Expression and genetic analysis of microRNAs involved in multiple sclerosis

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 4375-4384

  Ridolfi, Elisa ^a   Fenoglio, Chiara ^a   Cantoni, Claudia ^a   Calvi, Alberto ^a   De Riz, Milena ^a   Pietroboni, Anna ^a   Villa, Chiara ^a   Serpente, Maria ^a   Bonsi, Rossana ^a   Vercellino, Marco ^b   Cavalla, Paola ^b   Galimberti, Daniela ^a   Scarpini, Elio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Association analysis; Gene expression; microRNA; Smultiple sclerosis

Indexed keywords

MICRORNA; MICRORNA 15B; MICRORNA 223; MICRORNA 23A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84875061922     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14034375     Document Type: Article

References (27)

1. Miller, A.E. Multiple sclerosis: Where will be in 2020? Mt. Sinai J. Med. 2011, 78, 268-279.
2. Stys, P.K.; Zamponi, G.W.; van Minnen, J.; Geurts, J.J.G. Will the real multiple sclerosis stand up? Nat. Rev. Immunol. 2012, 13, 507-514.
3. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
4. Fenoglio, C.; Ridolfi, E.; Galimberti, D.; Scarpini, E. MicroRNAs: Active players in the pathogenesis of Multiple Sclerosis. Int. J. Mol. Sci. 2012, 13, 13227-13239.
5. Du, C.; Liu, C.; Kang, J.; Zhao, G.; Ye, Z.; Huang, S.; Li, Z.; Wu, Z.; Pei, G. MicroRNA miR-326 regulates Th-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10, 1252-1259.
6. Xiao, C.; Srinivasan, L.; Calado, D.P.; Patterson, H.C.; Zhang, B.; Wang, J.; Henderson, J.M. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9, 405-414.
7. Guerau-de-Arellano, M.; Smith, K.M.; Godlewsky, J.; Liu, Y.; Winger, R.; Lawler, S.E.; Whitacre, C.C.; Racke, M.K.; Lovett-Racke, A.E. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 2011, 134, 3578-3589.
8. Otaegui, D.; Baranzini, S.E.; Armananzas, R.; Calvo, B.; Munoz-Culla, M.; Khankhanian, P.; Inza, I.; Lozano, J.A.; Castillo-Trivino, T.; Asensio, A, et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009, 4, e6309.
9. Martinelli-Boneschi, F.; Fenoglio, C.; Brambilla, P.; Sorosina, M.; Giacalone, G.; Esposito, F.; Serpente, M.; Cantoni, C.; Ridolfi, E.; Rodegher, M, et al. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett. 2012, 508, 4-8.
10. Cox, M.B.; Cairns, M.J.; Gandhi, K.S.; Carroll, A.P.; Moscovis, S.; Stewart, G.J.; Broadley, S.; Scott, R.J.; Booth, D.R.; Lechner-Scott, J, et al. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5, e12132.
11. Junker, A.; Krumbholz, M.; Eisele, S.; Mohan, H.; Augstein, F.; Bittner, R.; Lassmann, H.; Wekerle, H.; Hohlfeld, R.; Meinl, E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009, 132, 3342-3352.
12. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
13. Haghikia, A.; Haghikia, A.; Hellwig, K.; Baraniskin, A.; Holzmann, A.; Décard, B.F.; Thum, T.; Gold, R. Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study. Neurology 2012, 79, 2166-2170.
14. Ajit, S.K. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors 2012, 12, 3359-3369.
15. Fenoglio, C.; Ridolfi, E.; Cantoni, C.; De Riz, M.; Pietroboni, A.; Serpente, M.; Villa, C.; Bonsi, R.; Bresolin, N.; Piccio, L, et al. Decreased circulating miRNAs in patients with multiple sclerosis. Mult. Scler. J. 2011, 18(S4), 255-277.
16. Zampetaki, A.; Willeit, P.; Drozdov, I.; Kiechl, S.; Mayr, M. Profiling of circulating microRNAs: From single biomarkers to re-wired networks. Cardiovasc. Res. 2011, 93. doi:10.1093/cvr/cvr266.
17. Keller, A.; Leidinger, P.; Lange, J.; Borries, A.; Schroers, H.; Scheffler, H.P.; Lenhof, H.P.; Ruprecht, K.; Meese, E. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing remitting disease from healthy controls. PLoS One 2009, 4, e7440.
18. De Santis, G.; Ferracin, M.; Biondani, A.; Caniatti, L.; Tola, R.; Castellazzi, M. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 2010, 226, 165-171.
19. Redis, R.S.; Calin, S.; Yang, Y.; You, M.J.; Calin, G.A. Cell-to-cell miRNA transfer: From body homeostasis to therapy. Pharmacol. Ther. 2012, 136. doi:10.1016/j.pharmthera.2012.08.003.
20. Yang, M.; Chen, J.; Su, F.; Yu, B.; Su, F.; Lin, L.; Lui, Y.; Huang, J.D.; Song, E. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 2011, 10, 117.
21. Li, T.; Morgan, M.J.; Choksi, S.; Zhang, Y.; Kim, Y.S.; Liu, Z.G. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 2010, 11, 799-805.
22. Clemente, D.; Ortega, M.C.; Arenzana, F.J.; de Castro, F. FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions. J. Neurosci. 2011, 31, 14899-14909.
23. Sarchielli, P.; Di Filippo, M.; Ercolani, M.V.; Chiasserini, D.; Mattioni, A. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci. Lett. 2008, 435, 223-228.
24. Lin, S.T.; Fu, Y.H. MiR-23 regulation of lamin B1 is crucial for oligodendrocyte development and myelination. Dis. Model Mech. 2009, 2, 178-188.
25. Vogt, L.; Schmitz, N.; Kurrer, M.O.; Bauer, M.; Hinton, H.I.; Behnke, S.; Gatto, D.; Sebbel, P.; Beerli, R.R.; Sonderegger, I, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J. Clin. Invest. 2006, 116, 2817-2824.
26. Polman, C.H.; Reingold, S.C.; Edan, G.; Filippi, M.; Harthung, H.P.; Kappos, L.; Lublin, F.D.; Metz, L.M.; McFarland, H.F.; O'Connor, P.W, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58, 840-846.
27. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25, 402-408.